Isopropyl isothiocyanate - Compound Card

Isopropyl isothiocyanate

Select a section from the left sidebar

Isopropyl isothiocyanate

Structure
Zoomed Structure
  • Family: Plantae - Moringaceae
  • Kingdom: Plantae
  • Class: Thiocyanate
Canonical Smiles CC(N=C=S)C
InChI InChI=1S/C4H7NS/c1-4(2)5-3-6/h4H,1-2H3
InChIKey VHBFEIBMZHEWSX-UHFFFAOYSA-N
Formula C4H7NS
HBA 2
HBD 0
MW 101.17
Rotatable Bonds 1
TPSA 12.36
LogP 1.5
Number Rings 0
Number Aromatic Rings 0
Heavy Atom Count 6
Formal Charge 0
Fraction CSP3 0.75
Exact Mass 101.03
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Diplotaxis harra Cruciferae-Brassicaceea Plantae 308281
2 Erucaria microcarpa Cruciferae-Brassicaceea Plantae 1078594
3 Moringa peregrina Moringaceae Plantae 161031

Showing of synonyms

  • Hashem FA, Saleh MM (1999). Antimicrobial components of some cruciferae plants (Diplotaxis harra Forsk. and Erucaria microcarpa Boiss.).. Phytotherapy Research,1999,13(4),329-332. [View]
  • Kær A, Malver O, et al. (1979). Isothiocyanates in Myrosinase-treated Seeds Extract of Moringa Peregrina. Phytochemistry, 1979, 18(9), 1485-1487. [View]

No compound-protein relationship available.

No scaffolds available.

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.33
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-3.73
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-3.22

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.08
Plasma Protein Binding
4.01
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Inhibitor
CYP 2D6 Substrate
Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
8.04
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Safe
Bioconcentration Factor
0.39
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Toxic
Eye Irritation
Toxic
Maximum Tolerated Dose
0.97
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.56
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
3.67
Rat (Acute)
2.67
Rat (Chronic Oral)
1.28
Fathead Minnow
5.45
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Toxic
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
139.96
Hydration Free Energy
-1.14
Log(D) at pH=7.4
1.38
Log(P)
2.27
Log S
-1.93
Log(Vapor Pressure)
0.42
Melting Point
-15.0
pKa Acid
10.62
pKa Basic
4.01

No predicted protein targets found for this compound.

Download SDF